Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06225674
Other study ID # Epi_002
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 6, 2023
Est. completion date March 6, 2024

Study information

Verified date January 2024
Source Episurf Medical Inc.
Contact Fredrik Zetterberg
Phone +46 70-839 62 33
Email fredrik.zetterberg@episurf.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a retrospective, observational, single-arm, multi-centre, post-market clinical investigation designed to verify clinical performance and safety of Episealer Talus post-operation for treatment of focal osteochondral defects on the talus bone in the ankle. This retrospective investigation aims to collect data from patients with focal osteochondral defects treated with Episealer Talus, to provide insight on the potential benefit of Episealer Talus in the treatment of focal osteochondral defects. The aim for the clinical investigation is to collect data from approximately 25 adult subjects who were treated for focal osteochondral defect with Episealer Talus implant in 6 clinics (Sweden and Germany) since January 2020, when the devices were CE-marked. The data collected for each subject will include demographics and data generated in relation to the surgery itself and the post-surgery phases including e.g. focal defect grade and position, collected through medical record review. Each subject will also be asked to complete a set of QoL questionnaires (SEFAS, FAOS and VAS).


Description:

This is a retrospective, observational, single-arm, multi-centre, post-market clinical investigation designed to verify clinical performance and safety of Episealer Talus post-operation for treatment of focal OCDs. The overall clinical investigation is based on the patient's reported outcome (PROs) from OCD patients previously treated with Episealer Talus implant after January 2020. In total approximately 25 adult subjects, male or female, from 6 clinics (Sweden and Germany) will be included in the investigation. Subjects will be identified by the investigational site team through medical record review and/or site knowing the subjects from performing the implantation after January 2020. Following collection of the subject´s signed informed consent, subject demographics, health- and surgery-related data will be collected from the subjects' medical records. Therefore, only one visit is planned for each subject during the clinical investigation. The performance variables relate to quality of life, and all subjects will be asked to fill in three questionnaires (SEFAS, FAOS and VAS). The overall duration of the investigation is estimated to be 4 months, including a 1 month recruitment period. Each subject is estimated to spend approximately 1-2 hour for completing the informed consent and completing the questionnaires. Subject´s participation in the clinical investigation will be terminated once the questionnaires have been completed and the site team considers all data collected for the subject.


Recruitment information / eligibility

Status Recruiting
Enrollment 25
Est. completion date March 6, 2024
Est. primary completion date March 6, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: - Signed Informed Consent Form - Patients = 18 years old at the time of index procedure - Patients who previously received Episealer Talus implant after January 2020 Exclusion Criteria: - "None"

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Episealer Talus implant
This is an observational study, no intervention will be done. The aim for the clinical investigation is to collect data from approximately 25 adult subjects who were treated for focal osteochondral defect with Episealer Talus implant in 6 clinics (Sweden and Germany) since January 2020.

Locations

Country Name City State
Germany Robert-Koch-Krankenhaus Apolda Apolda
Germany OrthoCentrum Hamburg Hamburg
Germany St. Elisabeth-Krankenhaus Salzgitter
Germany St. Ansgar Sulingen-Bassum Sulingen
Sweden Aleris Hand @ Fot Stockholm
Sweden FotCenter Stockholm

Sponsors (1)

Lead Sponsor Collaborator
Episurf Medical Inc.

Countries where clinical trial is conducted

Germany,  Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Other The retrospective investigation design includes a non-systematic assessment of the spontaneous reporting of AEs, ADEs, SAEs, SADEs, and DDs. All safety variables, deriving from the non-systematic assessment, will be tabulated for the Safety Population: AE, ADE, SAE, SADE, and DD. 1 hour
Primary Assessment of total SEFAS (self-reported foot and ankle score) outcome SEFAS data will be extracted from the patient´s reported outcome (PROs). Range 0-48, low score is better 1 hour
Secondary Assessment of total FAOS (Foot and Ankle Outcome Score) and subscale (pain, other symptoms, activities of daily living, sport and recreational function, FAOS data will be extracted from the patient´s reported outcome (PROs). Range 0-100, low score is better 30 minutes
Secondary Assessment of total Visual Analogue Scale and subsections (rest, walking running, climb steps) VAS data will be extracted from the patient´s reported outcome (PROs), Range 0-10, low score is better. 10 minutes
Secondary Surgery-related information Retrospective data collection 10 minutes
Secondary Additional clinical performance parameters of Episealer Talus implant Subject's and PI's treatment satisfaction (Self reported, scale 1-5 low score is better) 10 minutes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06216756 - Evaluating Cryopreserved Osteochondral Allograft Cores for the Treatment of Osteochondral Lesions in the Knee N/A
Completed NCT06078072 - Biomaterials and Mesenchymal Stem/Stromal Cells in the Treatment of Knee Articular Surface Lesions
Terminated NCT00945399 - Comparison of Microfracture Treatment and CARTIPATCH® Chondrocyte Graft Treatment in Femoral Condyle Lesions Phase 3
Completed NCT03385642 - Follow-Up Study Evaluating the Long Term Outcome of ChondroMimetic in the Treatment of Osteochondral Defects in the Knee
Recruiting NCT05124613 - The Impact of Covid-19 on Patients Waiting for Knee Surgery
Recruiting NCT04236492 - Study Protocol to Evaluate Clinical and Imaging Results of Knee Fresh Osteochondral Allografts
Not yet recruiting NCT06462040 - Evaluation of Clinical and Radiological Outcomes in Patients Undergoing Fixation of Osteochondral Fragments With Reasorbable Screws in the Knee Joint
Recruiting NCT03625180 - An Observational, Prospective Study of Patients With Chondral and/or Osteochondral Defects of the Knee Treated With NAMIC
Recruiting NCT03696394 - A Study to Evaluate the Efficacy of BioCartilage® Micronized Cartilage Matrix in Microfracture Treatment of Osteochondral Defects N/A
Recruiting NCT04364334 - Knee Registry (Knieregister)
Completed NCT03452098 - Post-Operative Rehabilitation of Knee Osteochondral Defect: A Case Series
Terminated NCT03036878 - ReNu™ Marrow Stimulation Augmentation N/A
Recruiting NCT03777735 - Human Bone Graft for Fixation of Osteochondral Defects in the Knee Joint
Recruiting NCT03908931 - Descriptive Study of the Reconstruction of Osteochondral Lesions of the Knee: Clinical and Imaging Results N/A